Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

2011150 citationsJournal Article

Authors

Emilio González‐Parra · Hospital Universitario Fundación Jiménez Díaz

María Luisa González‐Casaus · Hospital Central de la Defensa Gómez Ulla

António Galán de Mera · Hospital General Universitario De Valencia

Alberto Martínez-Calero · Hospital Nuestra Señora de Alarcos

Valentina Hernández Navas · Iberia (Spain)

Mariano Rodríguez · Hospital Universitario Reina Sofía

Alberto Ortíz

Abstract

In conclusion, lanthanum carbonate reduced phosphate load, as assessed by urinary phosphate excretion, and also reduced plasma FGF23 in CKD-3 patients. This occurs in the presence of unchanged normal serum phosphate levels.

Topics & Keywords

Parathyroid Disorders and Treatments Biomedical Research and Pathophysiology Magnesium in Health and Disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Nephrology Dialysis Transplantation

Volume 26, Issue 8, pp. 2567-2571

DOI: 10.1093/ndt/gfr144

Field-Weighted Citation Impact: 12.17